Aging and upper gastrointestinal disorders.

[1]  A. Andriulli,et al.  The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal antiinflammatory drugs: The role of gastroprotective drugs , 2003, Aging clinical and experimental research.

[2]  A. Pilotto,et al.  Aging and the gastrointestinal tract. , 2003, Italian journal of gastroenterology and hepatology.

[3]  A. Pilotto,et al.  Short‐ and long‐term therapy for reflux oesophagitis in the elderly: a multi‐centre, placebo‐controlled study with pantoprazole , 2003, Alimentary pharmacology & therapeutics.

[4]  C. Hawkey,et al.  Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors , 2003, Gut.

[5]  M. Cesari,et al.  Adverse Drug Reactions as Cause of Hospital Admissions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA) , 2002, Journal of the American Geriatrics Society.

[6]  W. Bilker,et al.  Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications. , 2002 .

[7]  Presents from patient , 2002, BMJ : British Medical Journal.

[8]  Anne Whitehead,et al.  Meta-Analysis of Controlled Clinical Trials , 2002 .

[9]  A. Pilotto,et al.  Long-Term Clinical Outcome of Elderly Patients With Reflux Esophagitis: A Six-Month to Three-Year Follow-up Study , 2002, American journal of therapeutics.

[10]  P. Malfertheiner,et al.  An approach to Helicobacter pylori infection in the elderly , 2002, Alimentary pharmacology & therapeutics.

[11]  A. Majeed,et al.  Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects , 2002, Gut.

[12]  Justin C.Y. Wu,et al.  Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial , 2002, The Lancet.

[13]  J. Hanlon,et al.  Use of Inappropriate Prescription Drugs by Older People , 2002, Journal of the American Geriatrics Society.

[14]  A. Sauaia,et al.  Process of care and outcomes for elderly patients hospitalized with peptic ulcer disease: results from a quality improvement project. , 2001, JAMA.

[15]  M. Franceschi,et al.  Efficacy of One-week Triple Therapies with Low-dose Rabeprazole and Clarithromycin plus Standard-dose Amoxicillin or Tinidazole for the Cure of H Pylori Infection in Elderly Patients , 2001 .

[16]  A. Pilotto,et al.  Cure of Helicobacter pylori infection in elderly patients: comparison of low versus high doses of clarithromycin in combination with amoxicillin and pantoprazole , 2001, Alimentary pharmacology & therapeutics.

[17]  W. Ettinger,et al.  A multicenter, randomized, controlled trial to evaluate the safety profile, tolerability, and efficacy of rofecoxib in advanced elderly patients with osteoarthritis , 2001, Aging.

[18]  F. Chan,et al.  Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. , 2001, The New England journal of medicine.

[19]  A. Whelton,et al.  Cyclooxygenase-2–Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis Patients , 2001, American journal of therapeutics.

[20]  S. Z. Zhao,et al.  Functional status and health-related quality of life of elderly osteoarthritic patients treated with celecoxib. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[21]  Y. Kinoshita,et al.  Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly , 2001, Journal of gastroenterology and hepatology.

[22]  Amnon Sonnenberg,et al.  Risk factors for erosive reflux esophagitis: a case-control study , 2001, American Journal of Gastroenterology.

[23]  T. Kennedy,et al.  The prevalence of gastro‐oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms , 2000, Alimentary pharmacology & therapeutics.

[24]  A. Pilotto,et al.  Pantoprazole versus one‐week Helicobacter pylori eradication therapy for the prevention of acute NSAID‐related gastroduodenal damage in elderly subjects , 2000, Alimentary pharmacology & therapeutics.

[25]  Kees,et al.  Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pylori , 2000, Alimentary pharmacology & therapeutics.

[26]  H. Garewal,et al.  Symptom severity and oesophageal chemosensitivity to acid in older and young patients with gastro-oesophageal reflux. , 2000, Age and ageing.

[27]  S. Benjamin,et al.  The aging esophagus. , 1999, Clinics in geriatric medicine.

[28]  L. Grande,et al.  Deterioration of esophageal motility with age: a manometric study of 79 healthy subjects , 1999, American Journal of Gastroenterology.

[29]  R. Hunt,et al.  The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta‐analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole , 1999, Alimentary pharmacology & therapeutics.

[30]  A. Pilotto,et al.  Efficacy of 7 day lansoprazole‐based triple therapy for Helicobacter pylori infection in elderly patients , 1999, Journal of gastroenterology and hepatology.

[31]  Leandro,et al.  The effect of antibiotic resistance on the outcome of three 1‐week triple therapies against Helicobacter pylori , 1999, Alimentary pharmacology & therapeutics.

[32]  A. Yip,et al.  CASE REPORT: Two cases of biliary papillomatosis with unusual associations , 1999, Journal of gastroenterology and hepatology.

[33]  E. Ferriolli,et al.  Aging, Esophageal Motility, and Gastroesophageal Reflux , 1998, Journal of the American Geriatrics Society.

[34]  Y. Kinoshita,et al.  Relationship between severity and symptoms of reflux oesophagitis in elderly patients in Japan , 1998, Journal of gastroenterology and hepatology.

[35]  A. Pilotto,et al.  The Long-Term Clinical Outcome of Elderly Patients with Helicobacter pylori-Associated Peptic Ulcer Disease , 1998, Gerontology.

[36]  A. Pilotto,et al.  Prevention of Acute NSAID-Related Gastroduodenal Damage: A Meta-Analysis of Controlled Clinical Trials , 1998, Digestive Diseases and Sciences.

[37]  A. Cameron.  Barrett's esophagus: prevalence and size of hiatal hernia , 1998, American Journal of Gastroenterology.

[38]  A. Pilotto,et al.  The effect of Helicobacter pylori infection on NSAID‐related gastroduodenal damage in the elderly , 1997, European journal of gastroenterology & hepatology.

[39]  G. Vantrappen,et al.  The aging oesophagus , 1997, Gut.

[40]  C. Hawkey,et al.  Peptic ulcer bleeding in the elderly: relative roles ofHelicobacter pylori and non-steroidal anti-inflammatory drugs , 1997, Gut.

[41]  A. Pilotto,et al.  Role of Helicobacter pylori Infection on Upper Gastrointestinal Bleeding in the Elderly (A Case-Control Study) , 1997, Digestive Diseases and Sciences.

[42]  R. Shaker,et al.  Frequency of gastroesophageal reflux events induced by pharyngeal water stimulation in young and elderly subjects. , 1997, The American journal of physiology.

[43]  Kenneth K Wang,et al.  Esophagitis associated with the use of alendronate. , 1996, The New England journal of medicine.

[44]  A. Pilotto,et al.  Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers , 1996, Alimentary pharmacology & therapeutics.

[45]  D. Ott,et al.  Functional abnormalities of the esophagus: a prospective analysis of radiographic findings relative to age and symptoms. , 1996, AJR. American journal of roentgenology.

[46]  Y. K. Chen,et al.  Gastroesophageal reflux disease in the elderly: more severe disease that requires aggressive therapy. , 1995, The American journal of gastroenterology.

[47]  R. Shaker,et al.  Effect of aging on the secondary esophageal peristalsis: presbyesophagus revisited. , 1995, The American journal of physiology.

[48]  R. Spiller,et al.  Impaired oesophageal transit of capsule versus tablet formulations in the elderly. , 1994, Gut.

[49]  O. James,et al.  Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis. , 1994, Age and ageing.

[50]  I. Räihä,et al.  Symptoms of gastro-oesophageal reflux disease in elderly people. , 1991, Age and ageing.

[51]  A. Pilotto,et al.  NSAID and Aspirin Use by the Elderly in General Practice , 2003, Drugs & aging.

[52]  A. Lophatananon,et al.  A nurse-delivered advice intervention can reduce chronic non-steroidal anti-inflammatory drug use in general practice: a randomized controlled trial. , 2002, Rheumatology.

[53]  A. Pilotto.  Helicobacter Pylori-Associated Peptic Ulcer Disease in Older Patients , 2001, Drugs & aging.

[54]  A. Pilotto,et al.  Treatment of Helicobacter pylori infection in elderly subjects. , 2000, Age and ageing.

[55]  D. Castell,et al.  Evidence for diminished visceral pain with aging: studies using graded intraesophageal balloon distension. , 1997, American Journal of Physiology.

[56]  M. Murakami,et al.  Therapeutic Effects of Lansoprazole on Peptic Ulcers in Elderly Patients , 1995, Journal of clinical gastroenterology.

[57]  J. Mold,et al.  Prevalence of gastroesophageal reflux in elderly patients in a primary care setting. , 1991, The American journal of gastroenterology.